What: After AbbVie Inc. (NYSE: ABBV) expanded a collaboration with the company to work on therapies for cystic fibrosis, shares in Galapagos NV (NASDAQ: GLPG) jumped 30.5% last month, according to S&P Global Market Intelligence.
What: After AbbVie Inc. (NYSE: ABBV) expanded a collaboration with the company to work on therapies for cystic fibrosis, shares in Galapagos NV (NASDAQ: GLPG) jumped 30.5% last month, according to S&P Global Market Intelligence.